<DOC>
	<DOCNO>NCT01968720</DOCNO>
	<brief_summary>The purpose study determine safety efficacy multiple dose CAT-2003 patient severe hypertriglyceridemia either naive refractory current therapy . The study evaluate effect CAT-2003 fast postprandial total triglyceride chylomicron triglyceride level patient severe hypertriglyceridemia . This single-blind study . All patient receive placebo 14 day treatment period CAT-2003 28 day treatment period .</brief_summary>
	<brief_title>Pilot Study To Assess CAT-2003 Patients With Severe Hypertriglyceridemia</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Lipid Metabolism Disorders</mesh_term>
	<criteria>Between 18 74 year Screening Severe Hypertriglyceridemia ( TG ≥ 500 mg/dL ) . If lipid lower therapy include statin , fibrates , and/or omega3 fatty acid , stable dose least 4 week prior Screening Body mass index ( BMI ) ≤ 45 kg/m2 History major cardiovascular event within 6 month Screening Type I diabetes mellitus use insulin History pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>